These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18213650)

  • 21. Use of mode of action in risk assessment: past, present, and future.
    Clewell H
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):3-14. PubMed ID: 15896438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistics for risk assessment of chemical carcinogens.
    Chen JJ; Chen YJ; Cheng KF
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(4):281-312. PubMed ID: 18000784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events.
    Simon TW; Simons SS; Preston RJ; Boobis AR; Cohen SM; Doerrer NG; Fenner-Crisp PA; McMullin TS; McQueen CA; Rowlands JC;
    Crit Rev Toxicol; 2014 Aug; 44 Suppl 3():17-43. PubMed ID: 25070415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cumulative risk assessment of pesticide residues in food.
    Boobis AR; Ossendorp BC; Banasiak U; Hamey PY; Sebestyen I; Moretto A
    Toxicol Lett; 2008 Aug; 180(2):137-50. PubMed ID: 18585444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species susceptibilities to chemical carcinogens: a critical appraisal of the roles of sex hormones (endocrine status) and nutritional influences.
    Toth B
    In Vivo; 2002; 16(3):161-6. PubMed ID: 12182110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data and literature gathering in chemical cancer risk assessment.
    Silins I; Korhonen A; Högberg J; Stenius U
    Integr Environ Assess Manag; 2012 Jul; 8(3):412-7. PubMed ID: 22275076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Framework analysis for the carcinogenic mode of action of nitrobenzene.
    Hsu CH; Stedeford T; Okochi-Takada E; Ushijima T; Noguchi H; Muro-Cacho C; Holder JW; Banasik M
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):155-84. PubMed ID: 17558784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment.
    Calabrese EJ
    Arch Toxicol; 2009 Mar; 83(3):203-25. PubMed ID: 19247635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.
    Williams GM; Iatropoulos MJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):6-15. PubMed ID: 18930102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the OECD on the development of national/international risk/safety assessment frameworks.
    Gaugitsch H
    Environ Biosafety Res; 2006; 5(4):219-22. PubMed ID: 17640512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying food proteins with allergenic potential: evolution of approaches to safety assessment and research to provide additional tools.
    Ladics GS; Selgrade MK
    Regul Toxicol Pharmacol; 2009 Aug; 54(3 Suppl):S2-6. PubMed ID: 19028539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide.
    Dourson M; Hertzberg R; Allen B; Haber L; Parker A; Kroner O; Maier A; Kohrman M
    Regul Toxicol Pharmacol; 2008 Dec; 52(3):264-89. PubMed ID: 18775759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of epidemiologic data in Integrated Risk Information System (IRIS) assessments.
    Persad AS; Cooper GS
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):137-45. PubMed ID: 18329062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining modes of action for biologically based risk assessments.
    Schlosser PM; Bogdanffy MS
    Regul Toxicol Pharmacol; 1999 Aug; 30(1):75-9. PubMed ID: 10464048
    [No Abstract]   [Full Text] [Related]  

  • 38. Biomarkers in aquatic plants: selection and utility.
    Brain RA; Cedergreen N
    Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
    Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
    Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.